CEO Today USA Awards

- A R I Z O N A - Exciting Findings Rowpar Pharmaceuticals has announced recently that an in vitro laboratory analysis showed that ClōSYS Ultra Sensitive Oral Rinse reduced SARS-CoV-2 (COVID-19 virus) up to 98.4%within 30 seconds without the use of any harsh chemicals like alcohol, hydrogen peroxide or povidone iodine. While there is no evidence that inactivating the COVID-19 virus in the mouth will impact disease transmission, the studies reinforce the antimicrobial strength of ClōSYS products. Clinical trials in progress at the University of California San Francisco are evaluating whether oral rinses can reduce the viral load in the mouth, which may, in turn, reduce the transmission of the disease. “These are exciting and potentially groundbreaking findings,” said Jim Ratcliff. “We know that the COVID-19 virus can be transmitted from person to person through spray droplets from the mouth, so this is an important first step in determining whether our oral care products can make a significant impact in reducing the chances of becoming ill or infecting others. There is a lot more to learn as we follow the science, but it’s a very positive start for our rinse formula.”